Assertio Holdings, Inc. (NASDAQ:ASRT) Director Heather L. Mason Buys 75,000 Shares

Assertio Holdings, Inc. (NASDAQ:ASRT) Director Heather L. Mason purchased 75,000 shares of the company’s stock in a transaction on Monday, November 18th. The stock was acquired at an average price of $0.80 per share, with a total value of $60,000.00. Following the completion of the purchase, the director now directly owns 287,650 shares in the company, valued at $230,120. This trade represents a 35.27 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link.

Assertio Stock Down 2.6 %

Shares of ASRT opened at $0.95 on Thursday. The company has a quick ratio of 1.57, a current ratio of 2.01 and a debt-to-equity ratio of 0.30. Assertio Holdings, Inc. has a 52-week low of $0.73 and a 52-week high of $1.80. The company has a market cap of $90.71 million, a PE ratio of -1.30 and a beta of 0.83. The business has a fifty day moving average of $1.10 and a 200 day moving average of $1.18.

Assertio (NASDAQ:ASRT) last released its earnings results on Monday, November 11th. The company reported ($0.03) EPS for the quarter, beating analysts’ consensus estimates of ($0.05) by $0.02. Assertio had a positive return on equity of 3.79% and a negative net margin of 54.46%. The firm had revenue of $29.20 million for the quarter, compared to analysts’ expectations of $29.29 million. During the same quarter in the prior year, the firm posted ($0.01) earnings per share. On average, sell-side analysts expect that Assertio Holdings, Inc. will post -0.17 EPS for the current year.

Analysts Set New Price Targets

ASRT has been the subject of a number of research reports. Maxim Group assumed coverage on shares of Assertio in a research report on Friday, July 26th. They set a “buy” rating and a $3.00 target price for the company. StockNews.com upgraded Assertio from a “hold” rating to a “buy” rating in a research report on Wednesday, November 13th.

Institutional Inflows and Outflows

Institutional investors have recently added to or reduced their stakes in the stock. Geode Capital Management LLC grew its stake in Assertio by 4.1% in the 3rd quarter. Geode Capital Management LLC now owns 1,074,852 shares of the company’s stock worth $1,269,000 after acquiring an additional 42,750 shares in the last quarter. XTX Topco Ltd bought a new position in Assertio in the third quarter worth approximately $203,000. Captrust Financial Advisors purchased a new position in Assertio during the 3rd quarter worth $26,000. Empowered Funds LLC raised its position in Assertio by 5.4% during the 3rd quarter. Empowered Funds LLC now owns 431,913 shares of the company’s stock valued at $510,000 after purchasing an additional 21,976 shares in the last quarter. Finally, GSA Capital Partners LLP bought a new position in shares of Assertio during the 3rd quarter worth $177,000. Hedge funds and other institutional investors own 48.96% of the company’s stock.

About Assertio

Assertio Holdings, Inc, a commercial pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis.